Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswireSep 10 04:00

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:39 · Ratings

Lacklustre Performance Is Driving Pacira BioSciences, Inc.'s (NASDAQ:PCRX) 26% Price Drop

Simply Wall StAug 30 19:55

Pacira BioSciences Analyst Ratings

BenzingaAug 13 21:59 · Ratings

Express News | Pacira Biosciences Inc : Truist Securities Cuts Target Price to $8 From $30

BreakingsAug 13 19:02

Express News | Pacira Biosciences Inc : Truist Securities Cuts to Sell From Buy

BreakingsAug 13 19:02